A series of surveys on assay for anti‐A/B antibody by Japanese ABO‐incompatible Transplantation Committee

Abstract

A periodical quality control survey is considered necessary to improve the accuracy of measurement. Anti-A/B Ab titer would provide useful information towards the prediction of rejection and the indication of treatments such as (double filtration) plasmapheresis, splenectomy, anti-CD20 monoclonal antibody and intravenous immunoglobulin. Standardization of the assay for anti-A/B Ab titer is essential for the fulfillment of a precise multicenter study, which will elucidate the significance of the measurement of anti-A/B Ab titer.